...
首页> 外文期刊>Medicine. >Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer
【24h】

Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer

机译:对局部晚期直肠癌行新辅助放化疗并经全直肠系膜切除术的患者少于12个淋巴结的肿瘤学影响

获取原文
获取原文并翻译 | 示例

摘要

A minimum of 12 harvested lymph nodes (hLNs) are recommended in colorectal cancer. However, a paucity of hLNs is frequently presented after preoperative chemoradiation (pCRT) in rectal cancer and the significance of this is still uncertain. The aim of this study is to analyze the impact of hLNs on long-term oncologic outcomes.A total of 302 patients with locally advanced rectal cancer who underwent pCRT and curative resection between 1989 and 2009 were reviewed. Patients were categorized into 2 groups according to the number of hLNs: <12 versus 12 LN. The 2 groups were compared with respect to 5-year disease-free and overall survival. The optimal number or ratio of hLNs was investigated in subgroup analysis according to LN status.The median follow-up was 57 months. Patient characteristics other than age did not differ between the 2 groups. The group with <12 LNs had more favorable ypTNM and ypN stage than those with 12 LNs. However, the long-term oncologic outcomes were not significantly different between the 2 groups. In subgroup analysis of ypN(-), the group with <5 hLNs had the most favorable oncologic outcomes. In ypN(+) cases, a higher LN ratio tended to be associated with poorer 5-year overall survival.The paucity of hLNs in locally advanced rectal cancer after chemoradiation did not imply poor oncologic outcomes in this study. In addition, <5 hLNs in ypN(-) patients could reflect a good tumor response rather than suboptimal radicality.
机译:建议在结直肠癌中至少采集12个淋巴结(hLN)。然而,直肠癌术前放化疗(pCRT)后经常出现少量的hLNs,其意义仍不确定。这项研究的目的是分析hLNs对长期肿瘤学结局的影响。回顾性分析了1989年至2009年间接受pCRT和根治性切除术的302例局部晚期直肠癌患者。根据hLN的数量将患者分为2组:<12 vs 12 LN。比较两组的5年无病生存期和总生存期。根据LN状况在亚组分析中研究hLN的最佳数量或比例。中位随访时间为57个月。两组之间除年龄外的其他患者特征无差异。少于12个LN的组的ypTNM和ypN阶段要好于那些12个LN的组。但是,两组的长期肿瘤学结局无显着差异。在ypN(-)的亚组分析中,hLNs小于5的组的肿瘤学结局最理想。在ypN(+)病例中,较高的LN比率往往与较差的5年总生存率相关。在本研究中,局部放疗后局部晚期直肠癌中hLN的缺乏并不意味着肿瘤学结局较差。此外,ypN(-)患者中的<5 hLNs可能反映出良好的肿瘤反应,而不是次优的根治性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号